VanEck Associates’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Sell |
|
|||||
|
2025
Q1 | $5.92M | Sell |
|
|||||
|
2024
Q4 | $7.68M | Buy |
|
|||||
|
2024
Q3 | $7.13M | Sell |
|
|||||
|
2024
Q2 | $11M | Sell |
|
|||||
|
2024
Q1 | $10.9M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Sell |
|
|||||
|
2023
Q3 | $17M | Buy |
|
|||||
|
2023
Q2 | $16.3M | Sell |
|
|||||
|
2023
Q1 | $18.8M | Sell |
|
|||||
|
2022
Q4 | $20.2M | Sell |
|
|||||
|
2022
Q3 | $16.7M | Sell |
|
|||||
|
2022
Q2 | $38M | Sell |
|
|||||
|
2022
Q1 | $66.4M | Buy |
|
|||||
|
2021
Q4 | $38.5M | Sell |
|
|||||
|
2021
Q3 | $57.3M | Buy |
|
|||||
|
2021
Q2 | $80.3M | Buy |
|
|||||
|
2021
Q1 | $27.9M | Sell |
|
|||||
|
2020
Q4 | $27.8M | Buy |
|
|||||
|
2020
Q3 | $13.8M | Sell |
|
|||||
|
2020
Q2 | $18.5M | Sell |
|
|||||
|
2020
Q1 | $56.9M | Buy |
|
|||||
|
2019
Q4 | $95M | Buy |
|
|||||
|
2019
Q3 | $85.9M | Buy |
|
|||||
|
2019
Q2 | $66.5M | Buy |
|
|||||
|
2019
Q1 | $38.2M | Sell |
|
|||||
|
2018
Q4 | $45.8M | Buy |
|
|||||
|
2018
Q3 | $59.2M | Sell |
|
|||||
|
2018
Q2 | $73.6M | Sell |
|
|||||
|
2018
Q1 | $73.6M | Sell |
|
|||||
|
2017
Q4 | $74.7M | Buy |
|
|||||
|
2017
Q3 | $56.7M | Buy |
|
|||||
|
2017
Q2 | $48M | Sell |
|
|||||
|
2017
Q1 | $59.6M | Buy |
|
|||||
|
2016
Q4 | $56.1M | Buy |
|
|||||
|
2016
Q3 | $45M | Buy |
|
|||||
|
2016
Q2 | $42.7M | Buy |
|
|||||
|
2016
Q1 | $38.5M | Sell |
|
|||||
|
2015
Q4 | $47.1M | Buy |
|
|||||
|
2015
Q3 | $33.9M | Buy |
|
|||||
|
2015
Q2 | $29.9M | Sell |
|
|||||
|
2015
Q1 | $70.4M | Buy |
|
|||||
|
2014
Q4 | $75.8M | Buy |
|
|||||
|
2014
Q3 | $62.4M | Buy |
|
|||||
|
2014
Q2 | $67.3M | Buy |
|
|||||
|
2014
Q1 | $65.9M | Buy |
|
|||||
|
2013
Q4 | $45.7M | Sell |
|
|||||
|
2013
Q3 | $42.7M | Sell |
|
|||||
|
2013
Q2 | $46.8M | Buy |
|